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Abstract
This article deals with metabolic-immune processes at rest and under stress conditions, which, in turn, results in the 
development of immune-dependent and immune-associated disorders. The article analyzes study results and conclu-
sions of various literature sources and experimental data in healthy individuals and patients suffering from non-specific 
inflammatory lung diseases; purulent-inflammatory diseases and their combinations, primary and secondary progres-
sive multiple sclerosis in the acute stage and remission. Research studies investigated the impact of the type, stage, 
combination of diseases on the parameters of the immunologic and metabolic statuses, as well as their correlations. 
The authors also analyzed metabolic effects of immunomodulators. Based on the analysis of the literature and own 
clinical and experimental data, the authors identified the ability of metabolic factors to regulate immunological pro-
cesses. A correlative analysis of examination results of the patients with various diseases helped detect the unity of the 
immune-metabolic mechanisms of pathology. The data on the therapeutic effect of various modulators through differ-
entiated biochemical chains and vice versa – the metabolic effect through immunological mechanisms –were analyzed 
in the study. Thus, one can testify that there is the phenomenon of a mediated effect of some immunocorrectors on the 
reactivity through metabolic chains. The fact that a number of modulators and metabolics can simultaneously affect the 
biochemical and immunological parameters of patients proved the above phenomenon. There was revealed a signifi-
cant correlation interaction of the immune-metabolic parameters with various types of purulent-inflammatory diseases, 
which proves the formation of a single mechanism of pathology.
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Introduction
The last decade has been characterized by an increase in 
purulent-inflammatory diseases (Ditkoff et al. 2018, Fal-
coni-McCahill 2019). This regularity results from redu-
ced herd immunity of the population due to a number of 
objective reasons, mutations of microorganisms, hygiene 
violations, and complications (Majdan 2016). Disorders 
of nonspecific and specific, regional and systemic mecha-
nisms of anti-infectious resistance play a significant role 
in the pathogenesis of diseases.
Persistent imbalance of protective reactions ultimately 
leads to a decrease in the body’s resistance to infections 
and other factors, the induction of chronic pathological 
processes and their relapses.
In addition, the problem of purulent-inflammatory diseas-
es remains one of the most important problems in the modern 
world, since they develop in every tenth patient with a high 
risk of the development of chronic diseases and their recur-
rence (Tomassetti and D’Hooghe 2018, Zhang et al. 2018).
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Treatment and diagnostic characteristics of patients 
can play a negative role (Dumesic et al. 2015). Firstly, 
surgical intervention and its therapeutic support are un-
conditional immunosuppressive factors. Secondly, all 
pharmacological and non-drug therapeutic measures 
actively stimulate or suppress immunological reactivi-
ty, which leads to the suppression of anti-infectious re-
sistance or induction of auto-aggressive and allergic re-
actions. Thirdly, diagnostic invasive and non-invasive 
procedures, on the one hand, also significantly distort the 
intensity and nature of protective reactions, whereas on 
the other hand result in infectious contamination of the 
examined patients with hospital aggressive or opportun-
istic microorganisms that cause the chronic course of in-
fectious processes and resistance to treatment (Kapral et 
al. 2018, Verwijs et al. 2019). These processes exacerbate 
immunological disorders in patients, form a vicious circle 
of aggravation of purulent-inflammatory diseases, cause 
their recurrence, and form a negative background for the 
development of complications (Bove et al. 2018). As a 
result, the immune system of patients is under multiple 
(stimulating, suppressing) pressure from the pathological 
inflammatory process itself due to impaired metabolic 
immunity (lipid and protein peroxidation, and antioxidant 
resistance disorders) (Goktas et al. 2019).
The phenomenon of metabolic immunity is intended 
to mean nonspecific regulation of immunogenesis by 
biochemical mechanisms (Forti et al. 2019). At rest, the 
immune-metabolic processes are well balanced, but this 
balance is disturbed under stress conditions, which leads 
to the development of immune-related or immune-asso-
ciated diseases (Zemskov et al. 2018). Various methods, 
including the correlation analysis of laboratory findings 
in healthy volunteers and patients suffering from multiple 
diseases, helped detect a wide range of metabolic factors 
responsible for immunological phenomena and vice versa 
(Zemskov et al. 2017).
Metabolic regulation of 
immunological reactions
Cyclic nucleotides
There is a single mechanism in the body that regulates the 
biochemical processes and functions of cells belonging to 
various organs, including the immune system: 3’5’ adeno-
sine monophosphate (3’5’ – AMP) and 3’5’ guanosine 
monophosphate (3’5’ – GMP). These compounds can be 
considered as secondary intracellular messengers mediating 
the action of extracellular factors. The formation of cyclic 
nucleotides is associated with the activity of enzymes – ade-
nylyl and guanylate cyclase, being components of cell mem-
branes (Aronsson et al. 2014, Soto-Velasquez et al. 2018).
b2-adrenergic stimulants, catecholamines, hormones 
of the anterior pituitary, glucagon, vasopressin, prosta-
glandins E, parathyroid hormone, histamine and other bi-
ologically active substances appear to be adenylyl cyclase 
activators. Guanylate cyclase is activated by cholinergic 
stimulants: acetylcholine, prostaglandins E, steroid hor-
mones and a number of other compounds. Phosphodi-
esterase is the enzyme that hydrolyzes cyclic nucleotides 
to inactive 5ʹ-AMP and 5ʹ- GMP. In this system, signif-
icant disorders are registered in various diseases, at the 
same time cAMP inhibits the immune system reactions, 
whereas cGMP stimulates them.
Thus, deficient adenylyl cyclase system is revealed 
in leukocytes in patients with bronchial asthma. A lower 
concentration of 3ʹ5ʹ-AMP is detected in the urine of the 
patients compared to that of the healthy individuals. The 
content of cAMP in the blood plasma increases during 
“acute bronchial asthma” and decreases in the remission 
stage of bronchial asthma, which indicates constantly pre-
dominant intracellular mediator of the cholinergic system. 
The low coefficient of cAMP/cGMP in the period of re-
mission of bronchial asthma results in a decrease in con-
trol over the synthesis of reaginic antibodies of class E 
and leads to their excessive formation. Therefore, a 3ʹ5ʹ-
AMP deficiency in patients with lung diseases is reported 
to be an unfavorable factor. It should be also noted that 
this system through certain hormones, for example, the 
pancreatic produce glucagon, regulates carbohydrate and 
lipid exchanges, which also play a part in non-inflammato-
ry pulmonary desease pathogenesis (Zemskov et al. 2017).
Nucleic acid exchange
The involvement of nucleic acids in the regulation of 
cells functioning, including cells of the immune system, 
is evidenced by the pronounced dynamics of the ribonu-
cleotide content in various pathological conditions: thy-
rotoxicosis, rheumatic heart disease, various infections, 
poisoning, radiation injuries, ulcers, bronchopulmonary 
disease, etc. (Zemskov et al. 2017). Multitude pathologi-
cal and physiological processes in the body result in the 
constant destruction of cells of various tissues, the release 
of nucleic acids, primarily RNA, which are destroyed 
into low-molecular oligonucleotides under the influence 
of endogenous nucleases; these low-molecular oligonu-
cleotides do not carry any genetic information, but have a 
general biological effect. For example, several hours later, 
under the influence of RNA, there is activated motility, 
absorption, metabolic ability of monocytes/macropha-
ges, production of humoral protection factors (lysozyme, 
complement, interferon, etc.) are observed in.
Later, there follows stem cell differentiation, T-B cells 
and macrophages cooperation, antibodies generation, 
the body desensitization via the enzymatic and cellular 
mechanisms, the derepression of immune memory cells, 
antigen redeposition, etc. As a result, the body reproduces 
a number of immunological phenomena: tachyphylaxis, 
which is a rapid non-specific antimicrobial resistance; 
formation of antiviral interferons; adjuvance, which is a 
non-specific enhancement of specific immune responses; 
a revaccinating effect due to antigens redeposition; and 
immunomodulation, which is normalization of perverted 
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defense reactions. Additional evidence of the immunotro-
py of low-molecular-weight nucleic acids is the detection 
of the direct correlative dependence of the serum RNA 
content on the level of undifferentiated leukocytes, T-cells 
and immunoglobulins of class A, and the reverse correl-
ative dependence – on “zero” lymphocytes in ulcers and 
bronchial asthma (Jung et al. 2018, Shi et al. 2019).
Protein exchange
C-reactive protein (CRP), a marker of an acute inflamma-
tory process, released when various cells are destroyed, is 
an important factor of the protein exchange. This protein 
first recruits into the affected area granulocytes, then mo-
nocytes/macrophages; binding to ligands, it accelerates 
the recognition of foreign antigens, activates phagocyto-
sis as the initial phase of the cellular immunity, promotes 
the development of humoral protection, and stimulates 
T-cytotoxic lymphocytes (Zemskov et al. 2017).
Other factors of protein metabolism are also immu-
notropic, which is documented by a strong correlation 
between the patients’ immunological and metabolic 
parameters. Thus, the dependence of the number of B 
cells on albumin, and the phagocytic number on α-1 and 
β-fractions was registered in children suffering from se-
rous meningitis. In the cases of a more severe damage 
to the meninges (in purulent meningitis), the formation 
of strong T-cell correlations and their regulatory subpop-
ulations with blood protein fractions was demonstrated. 
HbsAg carriers had a positive association of total protein 
concentration with IgM and IgA (Zemskov et al. 2017).
Statistically significant associations were found be-
tween the level of total protein and tests characterizing the 
functional activity of phagocytes (nitro blue tetrazolium 
spontaneous (NBTspont) and nitro blue tetrazolium activat-
ed (NBTactive)), concentrations of serum Ig A and Ig M in 
patients with superficial angiitis. The CRP concentration 
before treatment had a significant positive correlation with 
T-cells, and a negative correlation with the phagocytic 
number and immunoglobulins of classes A and M. In pa-
tients with deep angiitis, the total protein was positively 
associated with the phagocytic number, spontaneous and 
activated by NBT tests, negatively – with IgA and IgG. In 
these patients, albumin formed positive links with the level 
of immunoglobulins of classes A, M, and negative – with 
the CIC, NBTactive; while CRP formed positive links with T 
cells, phagocytic number, zero lymphocytes, and negative 
– with IgG and IgA, respectively (Zemskov et al. 2017).
Lipid metabolism
The effect of lipid levels on the main parts of the immu-
ne system was documented (Genest 2017). Hyperchole-
sterinemia was associated with an increased number of 
T-helper cells (T-helpers), and a decreased number of 
T-suppressors/killer cells (T-killers). The accumulation of 
cholesterol in blood was associated with an increase in the 
number of B cells (B), and its deficiency was due to their 
insufficiency (Alvarez-Curto and Milligan 2016). High 
levels of cytotoxic antibodies and T lymphocytes (T) with 
Fas/Apo-1 apoptosis antigen expression, which were de-
tected in patients with coronary heart disease, obesity and 
dyslipidemia; were significantly different from the cor-
responding parameters in patients without obesity (Og-
den et al. 2013, Shahwan et al. 2019). The concentration 
of aggressive circulating immune complexes (CIC) and 
IgM was also higher in patients with obesity (Kunz et 
al. 2019). At the same time, significant correlations were 
found between the number of cells with apoptosis mar-
kers and the body mass index, atherogenic lipid metabo-
lism parameters and creatinine phosphokinase.
On this basis, the directed modification of the com-
ponents of immunological reactivity through the regu-
lation of lipid metabolism seems to be a real possibility 
(Waldmann 2015). Vascular sclerosis is an example of 
the immunopathological condition based on lipid metab-
olism disorders. The formation of autoantibodies to the 
transport forms of cholesterol and its esters – high/low 
density lipoproteins – results in imbibition of the vessel 
walls. In patients with chronic bronchitis and bronchi-
al asthma, there was recorded an increase in the β-level 
of lipoproteins and cholesterol, which, on the one hand, 
compensated for lipid metabolism disorders, and, on the 
other hand, was a toxic factor of cell proliferation. At the 
same time, a direct correlative connection of hyperlipi-
demia with an increased concentration of auto-aggressive 
medium-weight molecules (MWM) was formed.
Carbohydrate metabolism
Three groups of regulators – catecholamines and thyroid 
hormones, stimulating glycolysis, and insulin, inhibiting 
it – appear to be the key participants in carbohydrate me-
tabolism. It was found that a change in glycogenolysis, 
damage to insulin receptors resulted in the development 
of autoimmune diseases with involvement of the thyroid 
gland, pancreas, and other organs (Xavier and Rutter 
2019). In patients with diabetes mellitus (DM), there was 
an increase in the level of immunoglobulins (Ig) and the 
CIC with a simultaneous decrease in the proliferative ac-
tivity of lymphocytes in response to mitogen. In patients 
with type 2 diabetes, the release of a factor that inhibits 
macrophage migration was reduced; in patients with both 
types of diabetes, the chemotaxis of neutrophils and their 
adhesive functions were weakened, and with ketoacidosis, 
phagocytosis was affected. There was a frequent combina-
tion of diabetes with thyroid pathology, which indicated 
the involvement of the immune system in an autoimmune 
pathology (Desai and Brinton 2019). Glycaemia reduction 
restored the function of immunocompetent cells. In pa-
tients with insulin-dependent diabetes, there was revealed 
a positive dependence of the content of lymphocytes ex-
pressing CD11b on the level of ceruleoplasmin (CP), glu-
tathione reductase (GR), plasma antioxidant activity, and 
peroxide resistance (PR); natural killers (NK) were posi-
tively dependent on CP; T-cells were negatively depen-
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dent on glutathione peroxidase (GPx) and positively de-
pendent on superoxide dismutase (SOD), and the number 
of B-lymphocytes, respectively, was dependent on SOD. 
Phagocytic absorption capacity was positively associated 
with malonic dialdehyde (MDA), negatively with PR, sys-
temic thiols, lipoproteins (LP), cholesterol, whereas oxy-
gen metabolism of neutrophils – with plasma antioxidant 
activity (Waldman 2015, Zemskov et al. 2017).
Metabolic syndrome
Metabolic syndrome (MS) is an example of a pathologi-
cal process combining lipid and carbohydrate metabolism 
disorders (Parikh and Mohan 2012). Metabolic syndrome 
includes: abdominal (visceral, android) obesity; type 2 di-
abetes, or impaired glucose tolerance; hypertension; and 
dyslipidemia. Examination of patients with MS revealed 
disorders of the immune system which were evident in a de-
crease in the number of T-lymphocytes, disimmunoglobuli-
nemia with increased levels of IgA and IgG. When metabo-
lic syndrome was combined with a thyroid gland pathology 
and chronic infectious diseases, an inversion of the immune 
status was observed with the development of deficiency in 
Tcyt, T-helpers, NK, and an IgG level (Bhargava et al. 2017).
According to (Mazloomzadeh et al. 2019), clinical 
models of psoriasis, ischemic heart disease (IHD), and 
their combinations (psoriasis + MS, IHD + MS) revealed 
the ability of the metabolic syndrome to determine: quan-
titative aggravation of changes in the parameters of car-
bohydrate, lipid, and cytokine metabolism, free-radical 
oxidation of lipids, proteins, the endogenous antioxidant 
system and endocrinological factors, mainly, with a stim-
ulating effect against the background of stimulating the 
pro- and anti-inflammatory cytokine formation. Using the 
coefficient of diagnostic consideration, the offset formu-
las for sentinel laboratory tests in patients suffering from 
the combined disorders – psoriasis + MS and IHD + MS 
– compared to solely psoriasis and IHD: SOD-2IL4+3HO-
MAIR+3 and HOMAIR+3 IL lβ+3 thyroid hormone (TH+3). 
In the first case, in patients with psoriasis, the metabolic 
syndrome caused a decrease in the activity of the anti-
oxidant superoxide dismutase enzyme, an increase in the 
concentration of anti-inflammatory IL4, and an insulin re-
sistance index; in the second - stimulation of HOMA IR, 
IL-lβ and thyroid hormone levels.
The state of the detoxifying function of the liver 
largely determines the level of immunological reactivity. 
Hepatocytes, being under constant pressure of stimuli of 
various chemical nature – xenobiotics – change metabo-
lism and enter the vascular bed of immunomodulating com-
pounds, for example, proteolytic and glycolytic enzymes 
(Liaskou et al. 2012). Healthy individuals demonstrated a 
positive correlation of cellular immune parameters with 
total bilirubin (tBili), conjugated bilirubins (conjBili), am-
ylase, thymol test, ASAT; humoral parameters had a posi-
tive correlation with tBili, unbound (free) bilirubin, and a 
negative correlation with conjBili. In patients with diabe-
tes mellitus, B-cells were associated with thymol test, and 
IgM – with thymol test, conjBili, and tBili. In Australian 
antigen carriers and patients with chronic viral hepatitis, 
these connections were progressively simplified according 
to an increase in the severity of immunological disorders 
(Bogdanos et al. 2013, Zemskov et al. 2017).
Enzyme immunomodulation is determined by pro-
teolytic and glycolytic enzymes of medical purposes. 
Endogenous and exogenous protease activation provides 
regulation of a T-dependent immune response. This is 
expressed in the in vivo reduction of T-and B-lympho-
cytes migration (Fig. 1), changes in the structure of the 
surface of lymphocytes and cell metabolism stimulating 
the incorporation of 3H-thymidine into the DNA of lym-
phocytes, an increased mitogenic effect of concanavalin 
A, and the removal of blocking factors from receptors of 
lymphoid cells (Zemskov et al. 2017).
Free-radical oxidation of lipids, proteins and antioxi-
dant protection
The treatment of immune-metabolic disorders in various 
pathological processes is based on the fact that free-radical 
oxidation (FRO) processes are central to cell metabolism, 
serve as a source of energy necessary for vital activity, 
prepare plastic material for creating and updating cellular 
structures, regulate reactions associated with metabolism 
of carbohydrates, lipids and proteins. During stepwise 
degradation of polyunsaturated lipids in FRO reactions, 
primary, secondary and final molecular products playing 
an important role in the processes of structural modifica-
tion of biomembranes and changes in their physicochemi-
cal properties are formed. The primary products include 
diene conjugates, ketodienes; the secondary products are 
malonic dialdehyde, bityrosine, and the end products are 
Schiff bases (Vilhardt et al. 2017).
Normally, the content of free-radical oxidation products 
is small, which is achieved by the presence of the constant-
ly functioning endogenous antioxidant protection system 
in the body, limiting the processes of free-radical oxidation 
of lipids and proteins by enzymatic mechanisms (super-
oxide dismutase, catalase, peroxidase, glutathione perox-
idase, proteins with mixed valence (transferrin, ceruleo-
plasmin), non-enzymatic factors (reduced glutathione, 
systemic thiols, antiradical activity of blood lipids), as 
well as β-carotene, retinol, α-tocopherol, polyunsaturated 
phospholipids, and ascorbic acid (Kiljan et al. 2019).
Combined immuno-metabolic 
modulation effects
The above data suggest the phenomenon of mediated action 
on the reactivity of some immunomodulators through me-
tabolic chains. The above phenomenon is evidenced by the 
implementation of simultaneous action by a number of mo-
dulators and metabolic agents on the biochemical and im-
munological parameters of patients (Zemskov et al. 2017).
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Metabolic effects of immunomodulators
After combining and analyzing the data of the studies on 
immunotropic drugs, it was identifed that they had a cer-
tain metabolic effect; perhaps in some cases it has not been 
studied yet (Kuzmenko et al. 2019). Thus, the metabolic 
effect of poly- and lipopolysaccharides was expressed in 
the intensification of protein synthesis, activation of the 
adenyl cyclase – cAMP system, and the 3H-thymidine in-
corporation into the spleen cells. Prodigiozan significant-
ly stimulated the activity of the glycolytic dehydrogenase, 
a key enzyme of the hexose monophosphate shunt (G-6-
PD), as well as succinate dehydrogenase, glutamate dehy-
drogenase, NADH-NADRN diaphorase, and lysosomal 
enzymes. The metabolic effect of levamisole was expres-
sed in stimulating the enzymatic activity of the hexose 
monophosphate shunt, protein iodization in neutrophils, 
synthesis of DNA and protein in lymphocytes and ma-
crophages, increased secretion of alpha-gluconidase and 
cathepsin D in phagocytes, accumulation of intracellular 
cGMP in lymphocytes and granulocytes. Muramildipep-
tide was able to activate various lysosomal enzymes and 
to determine an increase in the levels of cAMP, prostag-
landins, and DNA. Polyelectrolytes (PAA and P-4VP) 
in tissue culture contributed to the formation of DNA and 
RNA. Synthetic double-stranded RNA (dsRNA) - poly 
I:C, poly A:U, poly G:C increased the 3H-thymidine 
incorporation into lymphoid and other cells, stimulated 
the formation of adenylate cyclase, and cAMP. Thymus 
derivatives, myelopeptides, potentiated the synthesis of 
protein and nucleic acids in various cells. Thymomime-
tic agents turned out to be lipid metabolism regulators, 
reduced blood glucose levels, and normalized liver func-
tion indicators. In patients with chronic pyelonephritis, 
galavit resulted in the normalization of creatinine and 
bilirubin; super lymph – creatinine; derinat – urea, cre-
atinine, ALAT and ASAT (Hsu et al. 2015). Nucleic acid 
preparations – sodium nucleinate, ridostin, derinat, po-
ludan, isoprinosine – manifested not only differentiated 
immunocorrective, but also metabolic effects (Daniels et 
al. 2018). Thus, in the experimental models, monoribonu-
cleotide – AMP – reduced 10 times the amount of antibo-
dy formomg cells (AFCs) , whereas cytidine monophosp-
hate (CMP), uridine monophosphate (UMP) increased 
the amount of antibody-forming cells 9–19 times. At the 
same time, AMP activated antigen-specific suppressors 
and slowed down hormone replacement therapy (HRT). 
The maximum stimulation of the metabolism of macrop-
hages is determined by UMP, guanosine monophosphate 
(GMP), the minimum – by cMP and AMP. Purine nucleo-
Figure 1. T-lymphocytes.
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tides contributed, whereas pyrimidine nucleotides inhi-
bited the expression of lymphocyte receptors (Dellis and 
Papatsoris 2018). On the other hand, nucleotides and their 
components are part of ATP, GTP, UTP, CMP, a number 
of coenzymes and phospholipids necessary for the normal 
course of metabolic reactions (Yen et al. 2015). ATP is 
a source of energy; cytosine nucleotides are involved in 
lipid synthesis; uridine and guanine nucleotides – in the 
exchange of polysaccharides; guanine nucleotides – in the 
synthesis of proteins (Bhargava et al. 2017).
Immunological effects of metabolics
Hypoxen additionally prescribed to patients with chronic 
pyelonephritis determined the preferential normalization 
of immunological parameters with the standard formula of 
immunocorrection targets (FIT) - IgM-2 CIC-3 MWM +3) 
– the reduced levels of IgM, CIC, and MWM. The same 
agent resulted in the modification of various key targets in 
the immune system – leukocytes, lymphocytes, T-helpers, 
NK, Ig of the three main classes, phagocyte absorption ac-
tivity, pro-inflammatory cytokine concentration – IL4 – in 
patients with mixed, exogenous, endogenous asthma, and 
chronic obstructive pulmonary disease (Malik et al. 2018). 
Stimulation was the predominant vector of changes in these 
parameters (Zemskov et al. 2017). The similar results were 
obtained with the additional administration of food sup-
plements: patients with chronic pyelonephritis and chro-
nic salpingo-oophoritis were given cigapan; patients with 
chronic salpingo-oophoritis+ bacterial vaginitis were given 
tykveol; and patients with acute salpingo-oophoritis were 
given limontar. For example, the FIT of cigapan in chronic 
salpingo-oophoritis (NBTactive+3PhN+2PhI+2) was made of 
tests characterizing the absorbing and metabolic capacity 
of phagocytes; the FIT of cigapan in chronic pyelonephri-
tis (NKregulatory+3NKт-dependent+3IL4+3) – of tests characterizing 
two subpopulations of natural killers, IL4, etc. Cigapan in 
patients with herpetic keratitis had a differentiated effect on 
the immune system depending on the type of concomitant 
therapy: on the metabolic and absorbing capacity of phag-
ocytes, CIC or -–on T-helpers, CIC, NBTactive or – on CIC, 
Tcytotoxic, B cells; or – on T-helpers, IgA, and NK (Zemskov 
et al. 2018). Native protein drugs: amino acids – glutamic 
acid, methionine, cysteine, viceine, aminalon, hypophena-
te; human blood products = albumin, protein (albumin, α, 
β-globulins), aminocrovins (a solution of amino acids and 
low molecular weight peptides); protein hydrolysis pro-
ducts, casein, liver of cattle and pigs – hydrolysin (L-103), 
amopeptide, casein hydrolyzate, syrepar, fibrinosol were 
effective in treating the immunopathology of the cellular, 
humoral, and phagocytic immunity. Energizers (ribofla-
vin, nicotinamide), glycolysis activators (thiamine, ri-
boxin), stimulants of the tricarboxylic acid cycle (biotin, 
lipoate), proteolytic and glycolytic enzymes (trypsin, ter-
rilitina, lysozyme, hyaluronidase), vitamins (β-carotene, 
retinol, α-tocopherol); hepatoprotectors (essentiale, car-
sil, phosphoglyph); adaptogens (pantocrin, eleutherococ-
cus, esberitox); metabolics (potassium orotate, pentoxyl, 
methyluracil); eubiotics (acipol, acilact, baktisubtil) had a 
pronounced correcting effect on immunological disorders 
(Hauser et al. 2016).
Cyclic nucleotides inducing or inhibiting enzyme sys-
tems and functions of the elements of the immune sys-
tem seem to be the mediating mechanism of the action 
of metabolic processes on immunocompetent cells. It is 
known that 3,5-AMP inhibits neutrophil phagocytosis, 
proliferation and differentiation of lymphocytes, T-B-ef-
fector cells, cell-humoral reactions, and 3,5-GMP stimu-
lates these processes, as well as hypothetical receptors for 
nucleic acids on lymphoid and other cells.
Changes in immunological and 
metabolic parameters in various 
diseases
The subjects of studying the literature data and clinical 
and experimental research data were healthy individuals 
and patients suffering from nonspecific inflammatory lung 
diseases (NSILD – bronchial asthma, bronchitis, obstruc-
tive pulmonary disease); purulent-inflammatory diseases – 
acute and chronic cystitis, acute and chronic pyelonephri-
tis, acute and chronic salpingo-oophoritis, deep pyoderma, 
purulent soft tissue infection; combinations of chronic 
cystitis + chronic pyelonephritis, chronic cystitis + chronic 
salpingo-oophoritis; chronic pyelonephritis + urinary stone 
disease (USD), chronic pyelonephritis + benign prostatic 
hyperplasia (BPH); chronic salpingo-oophoritis + bacteri-
al vaginosis (BV), chronic salpingo-oophoritis + cervicitis, 
chronic salpingo-oophoritis + endometritis, deep pyoder-
ma with skin allergies, purulent infection of soft tissues 
with true eczema; multiple sclerosis with primary and se-
condary progressive forms (PPMS, SPMS) (Kaymakam-
zade et al. 2019), in the acute stage and remission. The 
authors studied the impact of the type, stage, combination 
of diseases on the parameters of the immunologic and me-
tabolic statuses, as well as their correlations (Geijer et al. 
2015, Germano et al. 2019, Huang et al. 2019).
Investigating the data from clinical and experimental 
studies of various foreign and Russian researchers, the 
following parameters were analyzed: the number of leu-
kocytes (L), lymphocytes (Lymph), mature and immature 
granulocytes (stabs and segmented), monocytes (M), ESR; 
clones and subclones of lymphocytes (T-cells – T, T-helper 
cells – T-helpers, T-cytotoxic cells – T-cytotoxic, T-regu-
lators - Tr, T-activated cells – T-activated, T-cell-depend-
ent natural killers– NKT-dependent, regulatory natural killer 
cells – NKregulatory, cytotoxic natural killer cells – NKcytotoxic, 
B-lymphocytes – B) were evaluated using flow cytofluor-
ometry NAVIOS Beckman Coulter and monoclonal anti-
bodies CYTO-STAT tetra CHROM, a biochemical analyz-
er Chospitec, Holland, spectrophotometric, turbodimetric, 
and immunoenzymatic methods; the absorbing and oxy-
gen-producing capacity of phagocytes (phagocytic index 
– PhI, phagocytic number – PhN, nitro blue tetrozolium 
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spontaneous – NBTspont, nitro blue tetrozolium activated – 
NBTactive), concentration of circulating immune complexes 
(CIC), serum immune globulins of the main classes (IgM, 
G, A), medium-weight molecules (MWM), pro-and an-
ti-inflammatory cytokines (IL-2, 4,6,6,8,10, TNF) were 
evaluated using sets by Protein Contour Company (Cruz 
2014, Ermishina et al. 2014, Malik et al. 2018).
The parameters of free-radical oxidation of lipids and 
proteins – diene conjugates, ketodienes, malonic dialde-
hyde (MDA), bi-tyrosine linkages, Schiff bases and indi-
cators of the antioxidant protection system – superoxide 
dismutase (SOD), catalase (K), vitamin E (VE), systemic, 
protein, non-protein thiols, plasma antioxidant activity – 
were determined using methods of UV spectrophotome-
try, fluorescence, reaction with 2-thiobarbituric acid, etc.
The analysis of the literature data on the problem re-
vealed that a number of researchers applied the modern 
panel of planning methods to support the relevance of 
the results obtained – randomization, representativeness 
of the sample according to L.E. Kholodov, V.P. Yakov-
lev formula (Zemskov et al. 2017), statistical analysis of 
the laboratory findings using parametric (Student’s) and 
non-parametric (Wilcoxon-Mann-Whitney) criteria de-
pending on the normal distribution of the parameters. The 
coefficient of diagnostic consideration (Кj) was calculated 
according to the formula (Gorelik, Skripkin):
( )
( )
2 2
1 2
2
2 1
2·
Kj
M M
δ δ+
=
−
,
where δ21 и δ
2
2 are mean root square deviations, М1, М2 – 
mean values of the parameters of the compared groups; 
the sentinel tests were determined with the following in-
terpretation: the lower the Kj module was, the more the 
parameter deviated from the target level.
All the analyzed data of the previous studies were 
comnined to formalize the key laboratory tests into the 
standard formulas of the immune system disorders and 
metabolic disorders and to reveal the specific regularity 
with reference to normal values in healthy people (See 
Tables 1 and 2).
Cystitis
With all thefindings on immunological and metabolic pa-
rameters from various scientific literature being combined 
in a single table (see Table 1), it can be seen that the follo-
wing parameters were the key parameters of the standard 
formula of the immune system disorders in acute cystitis: 
Tcytotoxic, Ig M, MWM, all with a stimulating vector of the 
3rddegree. Chronic cystitis was characterized by a decre-
ase in the number of T-helpers, IgA with the accumulation 
of pro-inflammatory interleukin 8 (Lai et al. 2014). The 
complication of chronic cystitis with chronic pyelo-
nephritis resulted in leukocytosis, T-cell deficiency, in-
hibition of the phagocyte absorption function of the 3rd-
degree (Amano and Shimizu 2014). The combination of 
chronic cystitis with chronic salpingo-oophoritis con-
tributed mainly to class A hyperimmunoglobulinemia, sti-
mulation of the Tactivated lymphocyte count, and inhibition 
of neutrophil oxygen metabolism of maximum or average 
severity. Specific features were detected when determi-
ning the reference metabolic parameters selected in pa-
tients for the formula of metabolic disorders. In this case, 
according to the criteria – the order, vector and degree 
of changes from the norm of the indicators – the com-
position of standard formulas was original in all cases. 
Thus, in acute cystitis, there was a medium decrease in 
the antioxidant parameter – anti-oxidant plasma activity 
against the background of the suppression of two enzy-
matic mechanisms of the antioxidant protection – catalase 
and superoxide dismutase. In chronic cystitis, stimula-
tion of the enzyme ceruleoplasmin, reduction of non-en-
zymatic systemic thiols and anti-oxidant plasma activity 
played the leading role (Keagy 2018). In chronic cystitis 
+ chronic pyelonephritis, there was observed a predo-
minant accumulation of free-radical oxidation parame-
ters – ketodienes, MDA combined with inhibition of the 
concentration of the antioxidant enzyme SOD. In chronic 
cystitis + chronic salpingo-oophoritis, there was a signi-
ficant increase in the level of MDA, inhibition of the en-
zymatic and non-enzymatic mechanisms of anti-oxidant 
protection – SOD and anti-oxidant plasma activity of the 
2nddegree (Bollestad et al. 2018).
Pyelonephritis
In patients with acute pyelonephritis, the key factors 
were: stimulation of the PhI, MWM, Tcytotoxic level, and the 
reduction of catalase, plasma anti-oxidant activity, and 
vitamin E. In chronic pyelonephritis, accumulation of 
B-cells, MWM, Schiff bases, MDA was observed along 
with inhibition of neutrophil metabolism and SOD. In 
the combination of chronic pyelonephritis with chronic 
cystitis, the key factors were: leukocytosis, T-cell defici-
ency, phagocytic number combined with an increase in 
the ketodienes, MDA concentration, and SOD deficiency. 
The combination of chronic pyelonephritis + chronic 
salpingo-oophoritis resulted in monocytosis, an excess 
of B-lymphocytes, a decrease in NBTsp, with stimulati-
on of the bi-tyrosine linkages formation, and a decrease 
in SOD and protein thiols. The combination of chronic 
pyelonephritis with USD resulted in the activation of 
the B-lymphocyte formation, CIC, Tcytotoxic suppressors, 
MDA, Schiff bases with a decrease in plasma anti-oxi-
dant activity. In chronic pyelonephritis + benign prostatic 
hyperplasia, there was a Tcytotoxicdeficiency, CIC overpro-
duction, a deficiency of pro-inflammatory IL6, diene con-
jugates, MDA, and systemic thiols.
Salpingo-oophoritis
An analysis of various clinical and experimental studies 
helped reveal that in patients with acute salpingo-oophori-
tis the sentinel tests of the standard formulas of the immu-
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Table 1. Sentinel Tests of the Key Formulas of Immune-metabolic Disorders and Their Correlations in Purulent-inflammatory and 
Other Diseases.
Disorders Formulas of immune system disorders Formulas of metabolic disorders Correlations
Mono purulent-inflammatory diseases
GP CIC+3 NKcyt+3 IL6+3 VE+3 МDА+2 plasma anti-oxidant 
activity-2
CIC+3+Schiff bases,-ceruleoplasmin; NKcyt+3 
–plasma anti-oxidant activity; IL6+3-systemic 
thiols
Acute pyelonephritis PhI+2 МWМ+3 Тcyt+3 К-1 plasma anti-oxidant activity-2 VE-1 PhI+2--MDA,+Schiff bases; MWM+3-plasma 
anti-oxidant activity
Chronic pyelonephritis В+3 MWM+3 NBTsp-2 Schiff bases+2
SOD-2 MDA+3
В+3+MDA; Тcyt+3-VE,-SOD
Acute salpingo-oophoritis TNF+3 CIC+3 IgМ+3 MDA+2 plasma anti-oxidant activity-1 
bi-tyrosine linkages Т-1
CIC+3-ceruleoplasmin; IgM+3+bi-tyrosine 
linkages
Chronic salpingo-oophoritis Т-3 IgM+3 IL6+3 VE+1 plasma anti-oxidant activity-1 
Schiff bases+2
Т-3+Schiff bases; IgМ
+
3+ceruleoplasmin; 
IL6+3+catalase
Acute cystitis Тcyt+3 IgM+3 MWM+3 plasma anti-oxidant activity-2 
catalase-1 SOD-1
Тcyt
+
3–bi-tyrosine linkages,-ketodienes; 
MWM+3 –VE
Chronic cystitis T-helpers-2 IgA-2 IL8+3 ceruleoplasmin+2 systemic thiols-3 
plasma anti-oxidant activity-2
T-helpers+2+diene conjugates;IL8+3-VE,-
systemic thiols.
Purulent infections of soft 
tissues
Тcyt
+
3 IL8+3 В-2 plasma anti-oxidant activity-3 
ketodienes+2MDA-1
Тcyt
+
3+MDA;В-2+plasma anti-oxidant activity 
+ catalase
Combined purulent-inflammatory diseases
Chronic cystitis+chronic 
pyelonephritis
L+3 Т-3 PhN-3 ketodienes+2 MDA+2 SOD-2 L+3+diene conjugates; Т3+Schiff bases,-SOD; 
PhN-3-catalase,-non-protein thiols
Chronic cystitis +chronic 
salpingo-oophoritis
IgA+3 Тac+2 NBTactive-3 MDA+3 SOD-2 plasma anti-oxidant 
activity-2
IgA+3–MDA,+plasma anti-oxidant activity;Т 
activated
+
2+ceruleoplasmin,+systemic thiols; 
NBTactive-3+bi-tyrosine linkages,+SOD, 
+catalase
Chronic salpingo-oophoritis 
+endometritis 
Т-2 NK+3 IgA+3 systemic thiols-2 VE-3 plasma anti-
oxidant activity-2
Т-2+VE,+ceruleoplasmin,+catalase;NK+3-
ketodienes; IgA+3+MDA,+plasma anti-
oxidant activity
Chronic salpingo-
oophoritis+bacterial vaginitis
T-helpers-2 CIC+3 Тactivated+3 ceruleoplasmin+2 systemic thiols-2 
plasma anti-oxidant activity-2
CIC+3+ketodienes, +Schiff bases, +bi-tyrosine 
linkages;Тactivated+3+SOD,+systemic thiols
Chronic salpingo-
oophoritis+cervicitis
IgG+2 NKcyt+2 IgM+2 ketodienes+2 bi-tyrosine linkages-2 
catalase-2
IgG+2-ketodienes,-plasma anti-oxidant 
activity; IgM+3-diene conjugates, +non-
protein thiols, +bi-tyrosine linkages 
Chronic salpingo-
oophoritis+chronic 
pyelonephritis
М+3 В
+
3 NBTsp-2 bi-tyrosine linkages+2 SOD-2 systemic 
thiols-2
М+2-VE,-systemic thiols; В+3–MDA,-bi-
tyrosine linkages,-catalase, +SOD; NBTsp-
2+ketodienes,-ceruleoplasmin
Chronic pyelonephritis+USD В+3 CIC+3 Tcyt+2 MDA+3 Schiff bases+2 plasma anti-
oxidant activity-3
В+3-Schiff bases,+plasma anti-
oxidant activity, +MDA, -catalase; 
CIC+ceruleoplasmin, -systemic thiols
Chronic pyelonephritis 
+BPH
Tcyt-3 CIC+3 IL6-2 diene conjugates-2MDA-1systemic 
thiols-3
Тcyt
+
3 +ketodienes.-MDA, +bi-tyrosine 
linkages; CIC+3-ceruleoplasmin; IL-2-
ketodienes,+plasma anti-oxidant activity
Deep pyoderma 
+skinallergies
eosinophils+3 В+3 TNF+3 systemic thiols-2 MDA+2 plasma anti-
oxidant activity-2
eosinophils+3+ketodienes,-plasma anti-
oxidant activity; В+3 +VE,-Schiff bases; 
TNF+3+bi-tyrosine linkages-,MDA,-systemic 
thiols
Purulent infections of soft 
tissues+true eczema
T-helpers-3 Тcyt+3 CIC+3 schiff bases+2 SOD-2 VE+3 T-helpers-3 +MDA,+diene conjugates,-SOD; 
Тcyt
+
3 –bi-tyrosine linkages,-ceruleoplasmin; 
CIC+3+bi-tyrosine linkages,-plasma anti-
oxidant activity
Note: GP – glutathione reductase, CIC – circulating immune complexes, VE – vitamin E, NK – natural killers, SOD – superoxide dismutase, MDA 
– malonic dialdehyde, Ig – immunoglobulin; TNF – tumor necrosis factor.
Table 2. Signaling Immuno-metabolic Risk Factors for Clinical Variants of Multiple Sclerosis (MS).
Clinical forms of MS Parameters
Immunologic Metabolic
PPMS Т, T-helpers, NKT-dependent, CIC, PhI, NBTspont MDA, Schiff bases, systemic thiols, VЕ, ceruleoplasmin, GP, GR
SPMS T-helpers,NKcytotoxic, HLA, В, PhI, NBTspont MDA, Schiff bases, systemic thiols, GP, GR
Acute stage Т, T-helpers, NKT-dependent , NKcytotoxic, В, NBTspont MDA, systemic thiols, VЕ, catalase, GP
Remission HLA, CIC, В, IgA, NBTspont MDA, diene conjugates, Schiff bases, systemic thiols, VЕ, catalase
Note: parameters of the standard formulas of the immune system disorders and metabolic disorders included in the key risk factors are given in bold; 
GP - glutathione reductase, GR - glutathione reductase, CIC - circulating immune complexes, VE - vitamin E, NK -natural killers, MDA - malonic 
dialdehyde, PPMS - primary progressive forms, SPMS - secondary progressive forms.
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ne system disorders and metabolic disorders, respectively, 
were: TNF α, auto-aggressive CIC, IgM and MDA, plas-
ma anti-oxidant activity and bi-tyrosine linkages. Chronic 
inflammation of the uterine appendages caused a predo-
minant decrease in the level of T-cells with accumulation 
of IgM and pro-inflammatory IL6. At the same time, in the 
patients there was the activation of vitamin B and Schiff 
bases formation and a decrease in plasma anti-oxidant ac-
tivity. Chronic salpingo-oophoritis complicated by chronic 
cystitis modified the qualitative composition of the formu-
las of immuno-metabolic disorders (MacLean et al. 2013). 
Accordingly, patients were diagnosed with hyperimmu-
noglobulinemia A, an excess of Tactive lymphocytes, a de-
creased amount of the neutrophil oxygen metabolism, and 
a stimulation of the MDA concentration with a decrease in 
SOD and plasma anti-oxidant activity. Bacterial vaginosis 
caused a predominant decrease in the T-helpers level, an 
increase in CIC, Tactive, the free-radical oxidation-ceruleo-
plasmin factor, suppression of the antioxidant protection 
factor – SOD parameters and plasma anti-oxidant activity 
(Desai and Brinton 2019, Faught and Reyes 2019).
In general, the above data demonstrate that as patho-
logical inflammatory processes in the urogenital organs 
transform from acute to chronic, from mono to combined, 
a quantitative and qualitative increase and differentiation 
of changes in the immunological parameters can be ob-
served, which is combined with pronounced variations in 
the metabolic components of the oxidative stress or vice 
versa (Kicha et al. 2018). To prove the correlations be-
tween these mechanisms, the authors applied methods to 
identify the key parameters of the disorders and their cor-
relation relationships.
Consistent changes in immuno-
metabolic parameters in various 
diseases
To prove the presence of a functional relationship between 
the immunological and metabolic parameters in patients 
with a wide range of pathological processes, a number 
of researchers used a correlation analysis determining the 
presence of strong relationships, with the coefficient of 
the above laboratory tests being > 0.6.
The clinical model of NSILD demonstrated that the 
content of T-cells, Tcytotoxic and T-helpers is inversely cor-
related with the level of free-radical oxidation products, 
which can be explained by the suppressive effect of this 
mechanism on the immune system, mainly, on the cellular 
link. Thus, the absolute amount of Tcytotoxic correlates with 
the content of MDA, GP, SOD, while T-helpers – with 
the concentration of MDA, GP, and SOD (Mikalsen et al. 
2018). The authors suggested that free-radical oxidation 
products have a toxic effect on T-lymphocytes, inhibit 
their proliferation, cause membrane destruction via dam-
age to the lipid layer, contribute to the formation of au-
toantigens and autoimmune reactions. At the same time, 
hyperlipidemia developing in patients causes inhibition of 
T-cell proliferation processes and distortion of intracellu-
lar metabolism with impaired functioning. A correlation 
analysis demonstrated that the investigated antioxidant 
protection values of blood were inversely interdepend-
ent on free-radical oxidation products, which shows the 
accumulation of toxic peroxide products that inhibit the 
activity of enzymatic and non-enzymatic mechanisms of 
anti-oxidant protection (Natsume 2019).
Additional information is provided by the analysis of 
strong correlations between the key immuno-metabolic 
indicators formalized into the typical formulas for im-
mune system disorders and metabolic disorders in pa-
tients with purulent-inflammatory diseases and multiple 
sclerosis (Tables 1 and 2).
The data in Table 1 indicate the presence of a signifi-
cant correlation interaction among the immune-metabolic 
parameters in patients with various types of purulent-in-
flammatory diseases of the bladder, kidneys and uter-
us appendages, which proves the formation of a single 
mechanism of pathology – immune-oxidant stress.
A different picture of the immune-biochemical corre-
lations was revealed with purulent-inflammatory dis-
eases. Thus, in acute cystitis, an increased number of 
Tcytotoxic was negatively associated with the free-radical 
oxidation parameter — bi-tyrosine linkages, whereas im-
mune-active MWM — with the non-enzymatic antioxi-
dant defense factor – vitamin E. In chronic cystitis, the 
character of correlations was different: a reduced number 
of T-helpers consistently varied along with the level of 
diene conjugates, whereas an excessive amount of IL-8 
was negatively dependent on the concentration of vitamin 
E and systemic thiols. In combination of chronic cystitis 
+ chronic pyelonephritis, leukocytes formed a positive 
correlation with diene conjugates, T-cells formed a neg-
ative correlation with Schiff bases and SOD, the phago-
cytic number also formed a negative correlation with 
catalase and non-protein thiols. In chronic cystitis com-
plicated by chronic salpingo-oophoritis, the number of 
strong bonds turned out to be maximal – 7. The content of 
IgA was negatively dependent on the amount of MDA and 
positively – on plasma anti-oxidant activity, whereas the 
number Tactivated consistently positively changed along with 
the levels of ceruleoplasmin, systemic thiols, bi-tyrosine 
linkages, SOD, and catalase (Bollestad et al. 2018).
In patients with acute pyelonephritis, the absorbing ca-
pacity of phagocytes was associated with free-radical oxi-
dation factors (MDA, Schiff bases), and MWM – with plas-
ma anti-oxidant activity. In chronic pyelonephritis, the 
reverse dynamics was observed – B cells were associated 
with one free-radical oxidation parameter (malonic dialde-
hyde), and MWMs were associated with two anti-oxidant 
protection tests – vitamin E and SOD. The combination 
of chronic pyelonephritis + chronic cystitis contributed 
to the correlation of leukocytosis with diene conjugates; T 
cells – with Schiff bases and SOD; PhN – with catalase and 
non-protein thiols. In chronic pyelonephritis + chronic 
salpingo-oophoritis, the number of monocytes depended 
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on the level of non-enzymatic mechanisms of anti-oxidant 
protection, vitamin E, and non-protein thiols; the num-
ber of B-lymphocytes depended on markers of the lipid 
free-radical oxidation, MDA proteins, bi-tyrosinelinkages, 
anti-oxidant protection enzymes – catalase, SOD; opera-
tional oxygen-dependent neutrophil metabolism depend-
ed on free-radical oxidation and anti-oxidant protection 
factors –ketodienes and ceruleoplasmin (Aronsson et al. 
2014). In patients with a combination of chronic pye-
lonephritis and USD, the number of B-cells consistently 
was changed in dependence on two free-radical oxidation 
parameters – Schiff bases and MDA, two anti-oxidant pro-
tection parameters – on plasma anti-oxidant activity and 
catalase; CIC concentration – on non-enzymatic mecha-
nisms of the anti-oxidant system – ceruleoplasmin and sys-
temic thiols. In patients with complex pathology – chronic 
pyelonephritis + BPH, the Tcytotoxic content correlated with 
three tests of free-radical oxidation – ketodienes, MDA, 
and bi-tyrosine linkages; the content of auto-active CICs 
correlated with ceruleoplasmin activity; the content of an-
ti-inflammatory IL 2 correlated with free-radical oxidation 
and anti-oxidant protection mechanisms – catalase and 
plasma anti-oxidant activity.
In acute salpingo-oophoritis, the correlation analysis 
revealed a strong correlation between the level of CIC 
and the non-drug factor of the anti-oxidant protection ce-
ruleoplasmin, as well as the correlation between immune 
globulins M and the free-radical oxidation parameter – 
bi-tyrosine linkages. In chronic inflammation of uter-
ine appendages, the key tests of formulas of the immune 
system disorders were associated with two free-radical 
oxidation parameters – Schiff bases, ketodienes and ce-
ruleoplasmin (an anti-oxidant protection parameter).
Chronic salpingo-oophoritis complicated by chron-
ic cystitis modified the qualitative composition of the for-
mulas of immunological and metabolic disorders. Thus, 
hyperimmunoglobulinemia A, an excess of Tactivated lym-
phocytes, a decrease in the neutrophilic oxygen metab-
olism, and a stimulation of malondialdegyde concentra-
tion along with a decrease in superoxide dismutase and 
plasma anti-oxidant activity were diagnosed in patients. 
The reference immunological tests of the formulas of the 
immune system disorders were consistently modified: 
IgA+3 – along with the level of MDA, +plasma anti-ox-
idant activity; Tactiv
+
2 – along with +ceruleoplasmin and 
+systemic thiols; NBTactiv
-
3 – along with +bi-tyrosine link-
ages, +SOD, and +catalase (Amano and Shimizu 2014). 
Bacterial vaginosis resulted in a significant dependence 
of the CIC concentration on the content of free-radical 
oxidation products – ketodienes, Schiff bases, and bi-ty-
rosine linkages, whereas Tactiv – on the anti-oxidant pro-
tection factors: superoxide dismutase and systemic thiols 
(Amano and Shimizu 2014).
Table 2 demonstrates mathematically distinguished im-
muno-metabolic risk factors for the formation of individ-
ual forms and stages of multiple sclerosis (Kiljan et al. 
2019). The fact that the key parameters of the formulas of 
the immune system disorders and metabolic disorders are 
included in the range of risk factors in the clinical forms 
of MS appears to be an indirect evidence of a certain unity 
of the immune-metabolic mechanisms of the pathology: in 
the primary progressive form – T, T-helpers, MDA, vitamin 
E, and GR; in the secondary progressive form – T-helpers, 
PhI, MDA, and Schiff bases; in the acute remittent stage – 
NKT-dependent, NKcytotoxicand MDA, Schiff bases; and also in 
the remission stage – CIC, IgA, MDA, and catalase.
Conclusion
Based on the analysis of various literature and clinical 
and experimental data, the authors determined the abili-
ty of metabolic factors – cyclic nucleotides, nucleic acid, 
protein, lipid, carbohydrate metabolism, metabolic syn-
drome, free-radical oxidation of substrates, antioxidant 
system, detoxifying systems of the liver, exogenous and 
endogenous enzymes – to regulate immunological pro-
cesses. A correlative analysis of the examination results 
of patients with various diseases – NSILD, purulent-in-
flammatory diseases, multiple sclerosis in primary and 
secondary progressive forms in acute stages and in remis-
sion stages – supported the unity of the immune-metabo-
lic mechanisms of pathology. The data on the therapeutic 
effect of modulators of various origins were analyzed 
through differentiated biochemical chains and vice versa 
– the realization of the effect of metabolics through im-
munological mechanisms.
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